COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

Mok Provides Insight on Preventing COVID-19 Peak in Hong Kong

April 9th 2020

Tony S. K. Mok, MD, BMSc, FRCPC, FASCO, discusses the impact of the COVID-19 outbreak on Hong Kong and explained how the implementation of early preventive safety measures may have contributed to the low incidence rate.

Florida Cancer Specialists Launches Telehealth Services in Response to Coronavirus (COVID-19)

April 8th 2020

Florida Cancer Specialists & Research Institute recently launched telehealth services across all Florida Cancer Specialists & Research Institute sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19.

At the Epicenter: How SCCA Braced Itself for COVID-19

April 8th 2020

When the first case of coronavirus disease 2019 was diagnosed in Washington on January 20, 2020 clinicians at Seattle Cancer Care Alliance decided to act expeditiously and unhesitatingly to minimize disease spread.

Selinexor COVID-19 Global Trial Launching

April 7th 2020

Selinexor, an FDA-approved drug for the treatment of patients with relapsed/refractory multiple myeloma, is being evaluated in a global randomized clinical trial as a potential treatment for hospitalized patients with severe COVID-19.

Shifting Lung Cancer Treatment Strategies in Response to COVID-19

April 7th 2020

Joshua M. Bauml, MD, discusses challenges in providing care to patients with lung cancer in light of the COVID-19 pandemic and ongoing efforts to reduce unnecessary exposure to the virus.

Leronlimab COVID-19 Trial Treats First Patients

April 7th 2020

The first 2 patients with COVID-19 have received treatment in a phase II trial exploring the investigational agent leronlimab, a CCR5 antagonist which has been advancing through the pipeline as a treatment for patients with triple-negative breast cancer.

The SARS COVID-19 Pandemic of 2020

April 6th 2020

The SARS COVID-19 virus pandemic came out of nowhere, circling the globe with shocking speed and with a vengeance.

Lung Cancer Experts in Ohio Share Day-to-Day Efforts to Quell COVID-19 Pandemic

April 6th 2020

Experts from The Ohio State University Comprehensive Cancer Center–The James as well as Blanchard Valley Health System discussed the impact of the COVID-19 pandemic on cancer care.

Weekly Webinar Series Part 6: Managing Lung Cancer Patients Through the COVID-19 Pandemic

April 6th 2020

In part 6 of our weekly COVID-19 Webinar Series, our panel of experts will share the latest updates and insights on the novel coronavirus. Join us Wednesday, April 29, 2020 at 8 PM EST.

Oncologists Band Together to Battle COVID-19 Crisis

April 5th 2020

An expert panel of oncologists addresses the oncology community’s response to the COVID-19 crisis.

Tocilizumab Successfully Treats COVID-19 in Patient With Myeloma

April 4th 2020

The oncology supportive care agent tocilizumab might effectively treat cytokine storm caused by COVID-19 in patients with blood cancers, according to a case study of a patient with multiple myeloma.

Dr. Mok Previews Discussion Topics for the Upcoming COVID-19 Webinar

April 4th 2020

Tony S. K. Mok, MD, BMSc, FRCPC, FASCO, previews discussion topics for the upcoming webinar hosted by OncLive on the novel coronavirus 2019 (COVID-19).

Ruxolitinib Phase III Trial Launching for COVID-19 Complications

April 3rd 2020

The oncology drug ruxolitinib is being explored in the planned phase III RUXCOVID trial as a treatment for cytokine storm in patients with COVID-19.

Borghaei Shares Long-Term Implications of COVID-19 on Cancer Care

April 3rd 2020

Hossein Borghaei, DO, MS, discusses the impact of COVID-19 on clinical practice and projected how the virus will change practice for the better in the long term.

Oncology Nursing and the COVID-19 Pandemic: What Nurses Need to Know

April 3rd 2020

This OncLive® webinar will focus on the impact of COVID-19 on oncology nursing care and will stream on Thursday April 23, 2020 at 8 PM EDT.

Cancer Centers Go On the Offensive to Reduce COVID-19 Risk

April 2nd 2020

From implementing telemedical approaches to resequencing treatments, cancer centers across the nation have nimbly adapted to face the clinical challenges posed by the novel coronavirus 2019 disease.

Weekly Webinar Series Part 5: Managing Lung Cancer Patients Through the COVID-19 Pandemic

April 2nd 2020

Part 5 of our weekly COVID-19 webinar series will stream on April 22, 2020 at 8 PM.

Oncologists Share How COVID-19 is Impacting Patients With Cancer

April 2nd 2020

OncLive interviewed experts at the State of the Science Summits™ in March 2020 on the impact of the COVID-19 pandemic on cancer care and shared what advice they have been giving their patients.

Cancer Vaccine Hits Early Benchmark in NSCLC, But COVID-19 Halts Phase III Trial

April 2nd 2020

OSE-2101 met the primary endpoint in the predefined Step-1 analysis of the phase III Atalante 1 trial in patients with HLA-A2 positive non–small cell lung cancer after failure of anti–PD-1/PD-L1 agents.

Dr. Bertino on the Impact of COVID-19 on Patients With Lung Cancer

April 2nd 2020

Erin M. Bertino, MD, a medical oncologist at The Ohio State University Comprehensive Cancer Center–James, discusses the potential impact of the novel coronavirus 2019 (COVID-19) on patients with lung cancer.